Tomato bushy stunt virus (TBSV), a tombusvirus with a non-segmented, plus-stranded RNA genome, codes for p33 and p92 replicase proteins. The sequence of p33 overlaps with the N-terminal domain of p92, which also contains the signature motifs of RNA-dependent RNA polymerases (RdRps) in its non-overlapping C-terminal portion. In this research, we demonstrate in vitro interactions between p33:p33 and p33:p92 using surface plasmon resonance analysis with purified recombinant p33 and p92. The sequence in p33 involved in the above protein -protein interactions was mapped to the C-terminal region, which also contains an RNA-binding site. Using the yeast two-hybrid assay, we confirmed that two short regions within p33 could promote p33:p33 and p33:p92 interactions in vivo. Mutations in either p33 or p92 within the short regions involved in p33:p33 and p33:p92 interactions decreased the replication of a TBSV defective interfering RNA in yeast, a model host, supporting the significance of these protein interactions in tombusvirus replication. D
Introduction
Viral RNA replication requires the assembly of replicase complexes in infected cells. These replicase complexes, which are found within characteristic membrane-containing structures such as multivesicular bodies, are known to contain the viral RNA template(s) and viral-and host-coded proteins (Buck, 1996; Noueiry and Ahlquist, 2003) . These factors are likely held together by protein -protein and protein -RNA interactions within the replicase complex. For example, the 1a and 2a replicase proteins of Brome mosaic virus (BMV), which are present within the BMV replicase, have been demonstrated to interact with each other using co-immunoprecipitation and the yeast twohybrid assays (Kao et al., 1992; O'Reilly et al., 1995 O'Reilly et al., , 1997 . In addition, 1a is also capable of intermolecular interaction with other 1a proteins, which might be important to bring two or more 1a proteins into complex with the 2a protein . The relevance of these intermolecular interactions was confirmed in replication studies in plant protoplasts using selected BMV mutants . Similarly, the 126K protein of Tobacco mosaic virus (TMV) was shown to form intermolecular interaction with other 126K proteins and with the 186K RNA-dependent RNA polymerase (RdRp) protein (Goregaoker et al., 2001; Watanabe et al., 1999) . Using temperature-sensitive 126K mutants in the yeast two-hybrid assay and for replication studies in protoplasts, Goregaoker et al. (2001) verified that the 126K -186K interaction is essential for TMV replication. Interestingly, analysis of purified recombinant 126K-containing complexes by electron microscopy revealed the formation of ring-like structures (possibly hexamers), though the function of this structure is currently unknown (Goregaoker and Culver, 2003) . Interaction among various replicase proteins has also been demonstrated for several other plus-stranded RNA viruses, including poliovirus (Hope et al., 1997; Lyle et al., 2002;  reviewed by Agol et al., 1999; Racaniello and Ren, 1996) , hepatitis C virus (reviewed by Tellinghuisen and Rice, 2002) , cucumoviruses (Suzuki et al., 2003) , and potyviruses (Schaad et al., 1997) .
Tombusviruses, including Tomato bushy stunt virus (TBSV) and Cucumber necrosis virus (CNV), are posi-tive-stranded RNA viruses of plants. The approximately 4.8 kb genomic (g)RNA codes for five proteins, of which two, namely p33 and p92, are essential for replication (Russo et al., 1994) . The signature motifs of RdRp are present in p92 (O'Reilly and , which is produced via ribosomal readthrough of the p33 stop codon. It has been estimated that the amount of p92 in infected cells is about 20-fold lower than p33 (Scholthof et al., 1995) . Both p33 and p92 proteins are present in the highly active purified RdRp preparation obtained from yeast co-expressing CNV p33 and p92 proteins and DI-72 RNA (Panaviene et al., in press ), suggesting that they might play direct roles in viral RNA synthesis. In vitro studies with the above CNV RdRp preparation demonstrated that the CNV RdRp could recognize essential promoter sequences (Panavas et al., 2002) , replication enhancers (Panavas and Nagy, 2003a; Panavas et al., 2003) and a replication silencer element during RNA synthesis. The significance of these cis-acting RNA elements in tombusviruses has been confirmed using plant protoplasts (Nicotiana benthamiana and cucumber) Panavas et al., 2003; Pogany et al., 2003; Ray and White, 2003) and yeast, a model host (Panavas and Nagy, 2003b) .
The function of p33 is not yet known, although it is likely involved in RNA replication, because (i) p92 could not support viral replication in the absence of p33 in plant protoplasts (Oster et al., 1998; and (ii) p33 has been demonstrated to bind to the viral RNA in vitro Rajendran and Nagy, 2003) . The RNA-binding region in p33, and the corresponding overlapping (pre-readthrough) region in p92, has been mapped to an arginine-proline-rich motif (RPR motif, Fig.  1 ), which is similar to the RNA-binding sequence of Tat protein in the Human immunodeficiency virus-1 (Rajendran and Nagy, 2003) . Mutations within the RPR motif in p33 affected gRNA and subgenomic (sg)RNA synthesis and RNA recombination , suggesting that p33 is a multifunctional protein. The RPR motif is also important for the function of p92 . In addition, the TBSV and CNV replicase proteins likely bind to intracellular membranes, based on studies with the closely related replicase proteins of Carnation Italian ringspot virus and Cymbidium ringspot virus, which have been shown to localize to multivesicular bodies (membranous structures derived from peroxisomes or mitochondria) (Burgyan et al., 1996; Rubino et al., 2001) .
Co-purification of p33 and p92 proteins in the RdRp preparation supported a model that direct interactions among these proteins might contribute to the stability of the RdRp complex. To test this hypothesis, in this paper, we examined if p33 and p92 could interact directly with each other using surface plasmon resonance (SPR) analyses with purified recombinant proteins and the yeast two- The five open reading frames coded by the TBSV genomic RNA (approximately 4800 nt long) are indicated with boxes and the noncoding sequences with solid lines. The known and predicted functional domains in the two overlapping replicase proteins, p33 and p92, are shown schematically. Y represents an amber stop codon-to-tyrosine codon mutation in p92 to facilitate its expression in E. coli and yeast. (B) SDS-PAGE analysis of purified recombinant p33 and p92 proteins and their derivatives, expressed as MBP fusion proteins in E. coli.
hybrid system. We demonstrated that p33 could interact with p92, and with other p33 molecules (intermolecular interaction). We identified two short regions within the Cterminal portion of p33, which promoted the aforementioned interactions. The significance of p33:p33 and p33:p92 interactions was confirmed in a model tombusvirus replication system in yeast by expressing p33 and p92 proteins carrying site-specific mutations within the region needed for protein interaction. Overall, these experiments supply direct evidence that the TBSV replicase proteins interact with each other, and that this interaction is important for the functions of the replicase proteins during tombusvirus infection.
Results and discussion

Interaction between the recombinant p33 and p92 replicase proteins in vitro
The TBSV and CNV p33 and p92 replicase proteins are present in the partially purified RdRp complex, which is capable of complementary RNA synthesis on added plus-or minus-stranded TBSV RNA templates (Nagy and Pogany, 2000; Panaviene et al., in press) . The RdRp complex might be held together by protein -RNA interactions and/or proteinprotein interactions between p33 and p92. To test if interaction between p33 and p92 (p33:p92) or between p33 and p33 (p33:p33) occurs, we used an in vitro protein interaction assay based on surface plasmon resonance (SPR) measure-ments. For this assay, we expressed recombinant p33 and p92 proteins in Escherichia coli as fusion proteins to the maltose binding protein (MBP) as described by Rajendran and Nagy (2003) . The p92 carried a tyrosine codon in place of the p33 stop codon to ensure the expression of the full-length p92 protein in E. coli (Fig. 1A ). This tyrosine mutation did not interfere with the wild-type (wt)-like function of p92 in a twocomponent complementation-based system, in which p33 and p92 are expressed from separate TBSV RNAs (Oster et al., 1998; . After affinity purification of the recombinant p33 and p92 (Fig. 1B , Rajendran and Nagy, 2003) , we carried out SPR measurements with a Biacore biosensor as described in Materials and methods. Briefly, the SPR assay provides real-time protein -protein interaction data (Crouch et al., 1999; Jokiranta et al., 2000) , by measuring the change in refractive index at the surface of the sensor chip due to change in mass resulting from proteinprotein interaction between the immobilized protein and the protein that is being passed over the sensor chip. For this study, we fixed the purified full-length MBP-p33 fusion protein onto the surface of a CM5 chip using amine-coupling reaction (Biacore). Then, comparable amounts of purified recombinant p33, p92, and MBP proteins diluted with the running buffer were passed separately over the immobilized MBP-p33 ( Fig. 2) . As predicted, we obtained strong signals (between 2000 and 8000 RU, resonance unit) when p33 and p92 were tested (Fig. 2) , demonstrating that both p33 and p92 interacted strongly with the immobilized MBP-p33. In contrast, the ''MBP only'' sample resulted in a signal that was only slightly above the background (Fig. 2) , indicating that Fig. 2 . Surface plasmon resonance analysis of interactions among TBSV replicase proteins. The p33 and p92 replicase proteins and their derivatives, expressed in E. coli, were affinity-purified as C-terminal fusions to MBP. The purified MBP-p33 was immobilized on CM-5 sensor chip, whereas p33, p92, MBP, p33N, and p33C (1 AM each) were separately injected in the running buffer over the chip. The interaction data shown were subtracted from the data from control surface (baseline) to account for bulk effects of running buffer and/or non-specific binding.
MBP interacted weakly with the immobilized MBP-p33 protein. It is also possible that the weak signal is due to non-specific binding of MBP to the dextran layer present on the surface of the sensor chip.
It is important to emphasize that the SPR signal (RU value) depends not only on the amount (the absolute number) of interacting molecules, but also on the molecular weight (MW) of the particular protein. Thus, the higher RU value for p33:p92 interaction than for p33:p33 interaction does not necessarily mean that the interaction between p33 and p92 is ''stronger'' than that between p33 and p33 because p92 has significantly higher MW than p33. In addition to the above observations, the SPR measurements also indicate that the binding between p33:p92 or between p33:p33 is stable (i.e., the dissociation was slow). Overall, based on the SPR measurements, we propose that the recombinant p33 can interact stably with other p33 molecules as well as with p92 in vitro.
To test what region in p33 is responsible for protein binding, we tested the interaction between p33 and two truncated p33 proteins, termed p33N and p33C ( Fig. 1A) . While p33N contains the N-terminal half of p33 with the putative membrane-spanning domain plus additional Nterminal sequences, p33C includes the C-terminal half of p33 with the RNA-binding domain (Fig. 1A ). Note that p33N and p33C do not overlap with each other and they have similar MW values. The SPR analysis with purified recombinant proteins demonstrated that p33C could efficiently interact with p33, while the interaction of p33N with p33 was weak (see comparable RU values for p33N and MBP-p33) (Fig. 2) . Interestingly, the interaction between p33 and p33C was rather strong (e.g., higher RU value in spite of the lower MW for p33C than for the fulllength p33) when compared to p33:p33 interaction in spite of the comparable molar amounts of proteins used in these assays. This suggests that the C-terminal region in p33 promotes interaction with p33, while the N-terminal hydrophobic domain in the full-length p33 may inhibit p33:p33 interaction. The opposing effects of the N-and C-terminal domains on p33:p33 interaction might serve as a regulatory function in vivo, which might affect the strength (stability) of the p33:p33 interaction. For example, the inhibitory effect of the N-terminal region of p33 might be negated when it is buried in membranous structures (due to the presence of the membrane-spanning domain, Fig.  1A ). Thus, the strength of p33:p33 interaction in cells might depend on the proximity of suitable membranes interacting with the N-terminal region of p33. Alternatively, it is also possible that the inhibitory effect of the Nterminal domain in p33 is due to the conditions in the in vitro assay, which allow the exposure of the hydrophobic sequences within the N-terminal domain due to the lack of membranes. Overall, these in vitro SPR experiments confirmed that p33 could interact with the C-terminal half of p33 and possibly with the prereadthrough (overlapping) sequence in p92.
The C-terminal sequence in p33 is essential for p33:p33 and p33:p92 interactions in the yeast two-hybrid assay To validate the above in vitro SPR-based observations on the interactions between p33:p33 and p33:p92, we also tested the interaction among the TBSV replicase proteins with the yeast two-hybrid assay (Matchmaker 3, BD Biosciences Clontech). This assay is based on the modular nature of the GAL4 transcription factor, where the DNAbinding domain (DB) and the transcription activation domain (AD) are fused separately to the test proteins. If there is interaction among the test proteins, then the BD and AD domains will be able to activate transcription allowing the yeast strain to grow on selective media. Using the above yeast two-hybrid assay, we found that yeast expressing p33 or p33N in any pair-wise combinations, such as p33:p33, p33:p33N, p33:p33C, p33N:p33N, did not grow on medium or high stringency media (Fig. 3) . In contrast, we did observe strong positive interaction when p33C was used in combination with p33C ( Fig. 3) . Thus, there is some discrepancy among the SPR measurements and the yeast two-hybrid data regarding the full-length p33. This might be due to the presence of the N-proximal hydrophobic membrane-spanning domains in p33 ( Fig. 1) , which might interfere with the nuclear localization of the fusion proteins that is required for detection of positive interactions in the yeast two-hybrid assay. Accordingly, protein interaction studies with full-length membrane-associated proteins have often led to negative results in the yeast two-hybrid assay (Stagljar and Fields, 2002; Van Aelst et al., 1993) . On the other hand, p33C lacking the membrane-spanning domain interacted with p33C in the yeast two-hybrid assay (Fig. 3) , as predicted from the in vitro SPR analysis. Overall, the Fig. 3 . Defining interactions among p33:p33 proteins of TBSV in the yeast two-hybrid assay. The yeast two-hybrid plasmids harboring GAL4 activation (AD) and binding domains (BD) fused to the p33 gene or its derivatives were co-transformed into AH109 cells. The transformed cells were serially diluted 10-fold and grown on three different selection media as shown. Growth on Trp À /Leu À indicates successful transformation of AH109 cells with plasmids. Growth on Trp À /Leu À /His À and Trp À /Leu À /His À /Ade À indicates transcriptional activation of HIS and ADE marker genes through interactions between AD and BD fusion proteins. The positive and negative controls included in the Matchmaker 3 system were used here. Proteins p33N and p33C represent N-and C-terminal halves of p33 protein (Fig. 1A) .
above experiments with the yeast two-hybrid assay confirmed that p33C could stably interact with p33C in vivo.
To test if p33C can also interact with the p92 protein in vivo, we used two truncated p92-derivatives in the yeast two-hybrid assay. The longer of the two proteins, termed p33C/92C (Fig. 4) , contained the p92 sequence except the N-terminal membrane-spanning domain (see explanation above), whereas the shorter protein, termed p92C, contained only the unique readthrough portion of p92 (Fig. 4) . The yeast two-hybrid test revealed that p33C interacted with p33C/92C, while it did not interact with p92C (Fig. 4) . Thus, the obtained data suggest that the interaction between p33 and p92 includes similar sequences with those responsible for intermolecular interaction between p33:p33. In contrast, the unique readthrough portion of the p92 (i.e., p92C, Fig. 1) , which contains the RdRp motifs, is unlikely to interact with p33 in vivo.
In general, the p33:p33 and p33:p92 interaction domains in TBSV p33 and p92 show similar arrangement to those found for the distantly related 126K/183K of TMV replicase proteins, which are also expressed via ribosomal readthrough mechanism (Buck, 1999) . For example, the C-terminal helicase-like domain of 126K protein interacted with the corresponding regions in 126K (intermolecular interaction) and in 183K, while the readthrough portion of the 183K protein carrying the RdRp motifs did not participate in this interaction (Goregaoker and Culver, 2001) . Additional similarity between the TBSV and TMV replicase proteins is the presence of an RNA-binding sequence in proximity to the protein interaction domain (Osman and Buck, 2003) . In spite of the similar arrangement of the above domains, the replicase proteins of TMV and TBSV likely perform different functions as well. For example, 126K might function as an RNA helicase and a capping enzyme (Merits et al., 1999; Goregaoker et al., 2003) , whereas p33 lacks these motifs.
Taken together the results shown in this paper suggest that the C-terminal region in p33 and the corresponding overlapping (pre-readthrough) sequence in p92 carry domains, which are likely responsible for assembly and/or stability of the replicase complex, while the major function of the readthrough portion of p92 might be complementary RNA synthesis.
Defining short amino acid stretches essential for p33:p33 interaction in yeast
To further delineate the sequences essential for the observed p33:p33 and p33:p92 interactions, we made a deletion library derived from p33C and tested it for interaction with p33C in the yeast two-hybrid assay (Fig. 5) . These experiments revealed that deletion of 26 or 46 amino acids (aa) from the C-terminus of p33C (in combination with deletion of 13 aa from the N-terminus) did not interfere with interaction with p33C (see constructs p33 181 -270 and p33 181 -250 , Fig. 5 ). Additional deletions of 10 or 36 aa from the C-terminus (constructs p33 181 -240 and p33 181 -214 Fig. 5 ) resulted in weak interaction with p33C on the medium stringency media, while no interaction was seen on the high stringency media. Thus, these experiments indicated that there is a 10 aa stretch in p33, termed site 1 (located between position 240 and 250 in p33) that is essential for p33:p33 interaction.
To test if there is additional sequence in p33, which might affect p33:p33 interaction, we made a further series of combined deletions from both the N-and the C-terminus of p33C, as shown in Fig. 5 . When tested in combination with p33C, we found that constructs that included a 13-amino acid stretch, termed site 2, between positions 271 and 283 (for example, constructs p33 271 -290 and p33 263 -283 , Fig. 5 ) interacted with p33C, based on yeast growth on both medium and high stringency media. Overall, these experiments defined that sites 1 and 2 within p33C were essential for interaction with p33C in vitro.
To confirm that the above two regions (i.e., site 1 and site 2) can independently interact with p33, we expressed p33 219 - Fig. 4 . Interaction between the TBSV p33 and p92 derivatives in yeast. (A) Schematic representation of the full-length p92 (p92 1 -818 ) and its deletion derivatives tested in the yeast two-hybrid assay. The positions of the amino acids (aa) present in particular p92 derivatives are shown on the right. (B) Data obtained in the yeast two-hybrid assay are shown with the specified constructs. See details from the legend in Fig. 3. amounts of the purified p33 219 -250 and p33 251 -296 proteins were then used in an SPR analysis when p33 was fixed on the surface of the chip (see above). These experiments demonstrated that both truncated p33 proteins interacted efficiently with p33 in vitro (Fig. 5B) . Therefore, we conclude that site 1 and site 2 within p33 can facilitate the interaction with p33 and possibly with p92 in vitro.
The presence of fusion proteins in yeast with no or reduced growth was detected by immunoblotting with anti-HA and anti-c-Myc antibodies against hemagglutinin (HA) and c-Myc epitope tags, which are present in BD and AD fusion proteins, respectively (BD Biosciences Clontech). This excludes the possibility that the expressed proteins were unstable in yeast.
Albeit site 1 and site 2 in p33 were able to promote interaction with the C-terminal region of p33 independently of each other in vitro and in the yeast two-hybrid assay, it is possible that they are part of a larger p33:p33 and p33:p92 interaction domain. A more detailed structure/function analysis of p33 will be necessary to identify the entire interaction domain and the critical amino acids within.
An interesting observation from this and earlier works (Rajendran and Nagy, 2003) is that the protein interaction and the RNA-binding regions are in close vicinity within the C-terminal half of p33, and the corresponding sequence in p92. Thus, it is possible that RNA-binding and p33:p33 interaction might affect each other. Accordingly, we observed cooperative RNA-binding by p33 in vitro (Rajendran Fig. 5 . Defining short regions in p33 that promote p33:p33 interaction. (A) Schematic representation of p33 and its deletion derivatives tested in the yeast twohybrid assay is shown on the left. The deleted sequences are indicated with solid lines. The two sites (site 1 and site 2) involved in p33:p33 interaction are boxed. The amino acid positions in particular p33 derivatives are shown in the center, whereas data obtained in the yeast two-hybrid assay with p33C (p33 169 -296 ) as bait are shown on the right. See details from the legend in Fig. 3. (B) Biosensor analysis of interactions between p33 and its two deletion derivatives, p33 219 -250 containing interaction site 1 and p33 251 -296 containing interaction site 2. The biosensor experiments were performed as described from the legend in Fig. 2. and , which suggests that p33:p33 interaction might stabilize binding of p33 to the viral RNA. The functional significance of cooperative binding by p33 is currently not known.
Mutations within interaction site 1 and site 2 of p33 and p92 inhibit replication of the TBSV replicon in yeast
To test if the above defined interaction site 1 and site 2 are important for replication, we took advantage of the recently developed TBSV DI RNA replicon system in yeast (Panavas and Nagy, 2003b) . The major advantage of this heterologous replication system for this work is that it allows the separate expression of the CNV (very closely related to TBSV, Fig. 6 ) p33 and p92 proteins from plasmids together with a TBSV-derived DI RNA replicon (termed DI-72 RNA), which is expressed from the galactose-inducible GAL1 promoter (Panavas and Nagy, 2003b) . The wt CNV p33 and p92 can efficiently support replication of DI-72 RNA even after the suppression of yDI-72 RNA transcription by glucose (Panavas and Nagy, 2003b) . Using the above yeast-based tombusvirus replicon system, we separately mutagenized p33 and p92 proteins within site 1 and site 2 and tested the abilities of the resulting mutated proteins to support DI-72 RNA replication in vivo. To this end, we mutated four separate amino acid residues to alanines. These include a tyrosine (Y 244 ) and an arginine (R 246 ) within site 1, and a phenylalanine (F 274 ) and a tyrosine (Y 276 ) within site 2 (Fig. 6) . These residues were mutated because they are highly conserved in tombusviruses (Fig. 6) , and that protein -protein interfaces can comprise of aromatic and charged residues surrounded by hydrophobic residues (Gallet et al., 2000; Ma et al., 2003) . When tested in the two-hybrid assay, Y 244 -A and R 246 -A mutations within site 1 decreased the number of yeast colonies on high-stringency media, suggesting that these mutations affected p33:p33 interaction (Fig. 7A) . Importantly, Y 244 -A and R 246 -A mutations present in either p33 or p92 supported very low level of DI-72 RNA replication in yeast at 30 jC (Fig. 7B ) or 34 jC (not shown). We conclude that these amino acids are important for the function of both p33 and p92 proteins. Because the mutated p33 proteins were present in comparable amount with the wt p33 in yeast (Fig.  7, Western) , we suggest that the Y 244 -A and R 246 -A mutations decreased the strength (stability) of interactions among the replicase proteins, which might have led to the assembly of less stable or less active replicase complexes in yeast. Similar to the site 1 mutants, the site 2 mutants, F 274 -A and Y 276 -A, also affected p33:p33 interaction and replication of DI-72 RNA in yeast. However, the observed effects were less pronounced for site 2 mutants than for the site 1 mutants on p33:p33 interaction in the yeast two-hybrid assay (Fig.  7A) and on DI-72 RNA replication in yeast expressing either mutated p33 or p92 (Fig. 7B) . Overall, these results support the model that p33:p33 and/or p33:p92 interactions are essential for tombusvirus replication.
In summary, for the first time we demonstrated direct interaction among the replicase proteins of a tombusvirus using an in vitro SPR method with purified recombinant proteins and in vivo using the yeast two-hybrid assay. The identified replicase protein interaction domain seems to be important for replication of a model tombusvirus template, suggesting that this interaction is essential for the assembly and/or function of the tombusvirus replicase.
Materials and methods
Biosensor assay
The recombinant proteins used for the biosensor assays were expressed as fusions to MBP in E. coli and purified as described by Rajendran and Nagy (2003) . The surface plasmon resonance (SPR)-based biosensor assays were carried out using BIACORE X (Biacore, Inc., Piscataway, NJ) at 25 jC. The running buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.05% surfactant P-20) and the protein immobilization buffer (10 mM sodium acetate, pH 5.0) were filtered and degassed before use. The sensor chip CM-5 and the amine coupling kit were purchased from Biacore. The purified recombinant MBP-p33 (see above) was dialyzed in the immobilization buffer to achieve a net negative charge to facilitate the coupling reaction and then immobilized onto CM-5 sensor chip by using the aminecoupling chemistry as recommended by the manufacturer. Briefly, the surface of both flow cells on the sensor chip was activated with a solution containing N-hydroxysuccinimide and N-ethyl-NV-(dimethylaminopropyl)-carbodimide for 7 min at the rate of 5Al/min. The purified MBP-p33 (100 Ag/ ml) was injected over the chip on flow cell #1 (Fc1) to immobilize the protein up to 12500 RU, which corresponds to approximately 12.5 ng/mm 2 , whereas flow cell #2 (Fc2) was left as the control surface to account for non-specific binding and bulk refractive index changes upon injection of protein samples, as suggested by the manufacturer. Both Fig. 6 . Sequence alignment of p33:p33/p92 interaction sites in tombus and related viruses. Interaction sites 1 and 2 are shown with bold-faced letters. The conserved amino acids selected for mutagenesis in the CNV sequence are boxed. The following abbreviations were used: TBSV, Tomato bushy stunt virus (cherry strain, top, and pepper strain, third row); CNV, Cucumber necrosis virus; AMCV, Artichoke mottled crinkle virus; CymRSV, Cymbidium ringspot virus; CIRV, Carnation Italian ringspot virus; MNeSV, Maize necrotic streak virus; and Pothos latent virus (PoLV, tombusviridae). flow cells were then deactivated using 1.0 M ethanolamine -HCl, pH 8.5, for 7 min at 5 Al/min and washed by repeated injections with the running buffer.
The protein -protein binding reactions were performed by injecting the purified test proteins (1 AM) that had been dialyzed in the running buffer, at the flow rate of 20 Al/min for 3 min followed by 3 min injection of the running buffer at the same flow rate. The interactions between the immobilized p33 and the tested recombinant proteins were analyzed in real time through a sensogram (Fig. 2) , in which the resonance units (RU) were plotted as a function of time. All the data shown in Fig. 2 were corrected based on data obtained from the control (Fc2).
Yeast two-hybrid assay
Yeast two-hybrid experiments were performed using the Matchmaker 3 two-hybrid system (BD Biosciences Clontech) based on the Yeast Protocol Handbook (BD Biosciences Clontech). To clone p33 and p92 genes into the yeast two-hybrid vectors pGADT7 and pGBKT7 (BD Biosciences-Clontech), we PCR-amplified them using the full-length T100 (Hearne et al., 1990 , supplied by A. White) and pHS175 clones (Scholthof et al., 1995, supplied by H. Scholthof) , which had the stop codon at the end of the p33 gene mutated to tyrosine to facilitate the production of p92 protein. The PCR products were cloned into plasmid Fig. 7 . Effect of mutations within p33:p33/p92 interaction sites 1 and 2 on DI RNA replication in yeast. (A) Two-hybrid interactions between TBSV p33C 169 -296 and the mutants (Fig. 6 ) generated by substituting selected amino acids with alanine in the protein interaction sites. Note that the mutations were introduced into truncated p33 proteins, either p33 241 -270 or p33 271 -290 as shown. (B) Northern blot analysis of the effects of the above mutations on replication of DI-72 RNA of TBSV. Yeast strain Sc1 was co-transformed with three plasmids coding for full-length wild type and/or full-length mutants of CNV replicase proteins (p33 and p92) as shown and a plasmid coding for the TBSV DI-72 RNA replicon. The position of the DI-72 RNA in the total RNA isolated from transformed yeast cells is shown on the right. The ethidium bromide-stained agarose gel with the 18S ribosomal RNA is shown in the middle as loading control. Western blot analysis of the amount of p33 present in yeast is shown below the agarose gel. The relative level of DI-72 RNA replication in yeast, based on quantification of the Northern blot using phosphorimager and ImageQuant (v1.2) software from three separate experiments, was plotted in the graph. vectors using EcoRI and BamHI restriction sites. Similar cloning strategy was used to make a series of deletion mutants in p33 and p92 with the help of primers listed in Table 1 . The sequences of the primers are described in Table  2 . PCR-based mutagenesis was used to create alanine substitution mutations as described by Rajendran and Nagy (2003) . To make internal deletions, sequences on both sides of deletions were PCR amplified separately with primers containing unique restriction sites (we selected the sites in such a way to keep the original amino acid sequence), followed by treatment with the appropriate enzymes and ligation. The ligated products were then re-amplified by PCR using the end primers containing EcoRI and BamHI restriction sites. Finally, we cloned the PCR products into the yeast two-hybrid vectors as described above. All the clones used for yeast two hybrid assay were confirmed by sequencing using T7 sequencing primer (Clontech).
Yeast strain AH109 (BD Biosciences Clontech) was cotransformed with 500 ng of individual plasmids using polyethylene glycol-lithium acetate (PEG/LiAC) method. The transformants were cultured on synthetic drop-out (SD) medium containing 2% (v/v) glucose and all amino acids except leucine and tryptophan (SD-Leu-Trp) at 30 jC for 3 -4 days as described in the Matchmaker 3 manual. The positive and negative control transformations were performed with the plasmids supplied by the manufacturer. Single colonies from each transformant were grown in 2 ml of SD medium containing 2% (v/v) glucose without leucine and tryptophan at 30 jC for 24 h (three repeats per each experiment). The culture densities were normalized with SD-Leu-Trp, followed by three times 10-fold serial dilution. Ten microliters of diluted cultures were grown on SD-Lue-Trp (low stringency), SD-Lue-Trp-His (medium stringency), and SD-Lue-Trp-His-Ade (high stringency) growth medium at 30 jC for 3-4 days. Lue, Trp, His, Ade denote amino acid residues leucine, tryptophan, histidine, and adenine respectively.
Replication assay for TBSV DI RNA in yeast
The yeast system for replication of DI RNA described by Panavas and Nagy (2003b) was adopted to study the role of interactions among replicase proteins (identified in the yeast two-hybrid assay) in DI RNA replication. Both p33 and p92 proteins were mutated separately at amino acid positions 244, 246, 274, and 276 by substituting alanine for tyrosine, arginine, phenylalanine, and tyrosine, respectively, using the Quick Change mutagenesis kit (Stratagene). The obtained p33 and p92 clones were sequenced using a reverse primer to 3V end of p33 gene of CNV (5V-GAGCTGCAGC-TATTTCACACCAAGGGA-3V).
The yeast plasmids expressing wild type and/or mutant replicase proteins (p33 and p92) were co-transformed with pYC-DI72 which codes for DI-RNA into yeast strain SC1 using the PEG/LiAc method. The transformants were grown at 30 jC in SD medium containing 2%(v/v) galactose without leucine, tryptophan, and uracil (SD-Leu-Trp-Ura). Individual colonies for each transformant were cultured in SD-Leu-Trp-Ura broth containing galactose at 24, 30, and 34 jC for 36, 24, and 20 h, respectively. The cells were then collected by centrifugation at 500 Â g for 2 min and resuspended in the RNA extraction buffer (50 mM sodium acetate, 10 mM EDTA and 1% SDS) and mixed thoroughly by vortexing in the presence of 50% water-saturated phenol. The mixture was then heated to 65 jC for 4 min, placed on ice for 2 min and centrifuged at 21,000 Â g for 4 min at Table 1 List of primer pairs used to make constructs described in text
Constructs a Primers
Surface plasmon resonance assay p33 3/4 p92 3/5 p92C 6/11 p33C 48/10 p33 219 -250 383/91 p33 251 -296 1188/10
Yeast two hybrid assay p92 473/475 p92C 187/475 p33C/92C 48/475 p33 473/474 p33 1 -160 (p33N) 473/620 p33 168 -296 (p33C) 183/474 p33 181 -214 75/1131 p33 181 -240 75/1132 p33 181 -250 75/1187 p33 181 -270 75/1143 p33 181 -296 75/474 p33 211 -240 76/1131 p33 211 -250 76/1187 p33 211 -296 76/474 p33 219 -296 383/474 p33 241 -257 1141/1142 p33 241 -270 1141/1143 p33 241 -296 1141/474 p33 251 -296 1188/474 p33 258 -296 1189/474 p33 263 -283 77/1202 p33 271 -290 1200/1201 p33 271 -296 1200/474 p33 241 room temperature. The aqueous phase was then mixed with two volumes of 95% ethanol and 0.1 volume of 3M sodium acetate pH 5.2. After 30 min at À20 jC, the RNA was pelleted by centrifugation at 21,000 Â g and washed with 70% ethanol for 5 min at 21,000 Â g at 4 jC. The RNA pellet was air-dried and resuspended in sterile water. The RNA was then electrophoresed in 1.5% agarose gel and transferred onto Hybond-XL membrane (Amersham) using a semi-dry transblot apparatus (BioRad) . The membrane was then treated with 2Â SSC for 3 min, air-dried, and UV-cross-linked using a crosslinker (Stratagene). The membrane was then probed with DI RNA-specific riboprobes, exposed to a phosphorscreen, and analyzed using a phosphorimager (Molecular Dynamics) as described by .
Preparation of crude protein extracts from yeast, SDS-polyacrylamide gel electrophoresis, Western blotting and immunodetection
Crude protein extracts from yeast were obtained as described by Kushnirov (2000) . Briefly, transformed SC1 yeast strains were grown in 2 ml of SD-Leu-Trp-Ura broth containing 2% galactose at 30 jC for 24 h. The cells were then harvested and resuspended in 100 Al sterile water. The cells were treated with 100 Al 0.2M NaOH at room temperature for 5 min, followed by a quick spin to remove the aqueous phase containing the alkali. The pellet was then resuspended in 50 Al 1Â SDS-PAGE loading buffer and the samples were boiled for 5 min. The cell debris was cleared by a quick spin and 6 Al of the supernatant was run in 8% Table 2 List of primers and their sequences used for PCR to generate constructs described in the text SDS-PAGE gel. The protein samples were then transferred from the gel onto PVDF membrane (Biorad). Immunodetection of p33 protein in the above samples was performed by using Anti-His monoclonal antibodies (Amersham) against the 6Â His-tag present at the N-terminus of the p33 protein (Panaviene et al., 2004) .
